Baclofen Treatment of Ataxia Telangiectasia

NCT00640003 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Ataxia Telangiectasia

Interventions

DRUG: Baclofen
DRUG: Placebo

Sponsor

Johns Hopkins University